期刊文献+

艾滋病患者抗病毒治疗初期不同部位HIV-1DNA比较研究 被引量:2

Comparison of HIV-1 DNA in different parts of early antiretroviral treatment patients
原文传递
导出
摘要 目的了解抗逆转录病毒治疗早期,外周血、肠黏膜相关淋巴组织及淋巴结中单个核细胞中HIV-1DNA量的差异。方法收集2006至2011年首都医科大学附属北京佑安医院规律随诊的留取有外周血、肠黏膜相关淋巴组织及淋巴结标本的HIV-1/AIDS患者,共11例。平均年龄39(25~55)岁,收集治疗前及治疗12周后患者的外周血、肠黏膜相关淋巴组织及淋巴结标本,用密度梯度离心法分离单个核细胞,用DNA抽提试剂盒提取DNA,用实时定量聚合酶链反应的方法检测HIV-1DNA拷贝数。用非参数检验方法分析比较各实验组之间HIV-1DNA拷贝数的差异。结果治疗前,不同部位HIV-1DNA量的差异具有统计学意义(χ2=17.636,P〈0.01),肠黏膜相关淋巴组织的HIV-1DNA量[(10714±2043)拷贝/10^6细胞]和淋巴结内[(9145±1202)拷贝/10^6细胞]高于外周血[(66±8)拷贝/10^6细胞,差异有统计学意义(U值均为0.00,P值均〈0.05)],治疗前淋巴结与肠黏膜相关淋巴组织中的HIV-1DNA量之间差异无统计学意义(U=46.00,P〉0.05);抗逆转录病毒治疗12周后,不同部位HIV一1DNA量的差异有统计学意义(χ2=22.000,P〈0.01);肠黏膜相关淋巴组织的HIV-1DNA量[(1701±790)拷贝/10^6细胞]和淋巴结内[(11591±1781)拷贝/10^6细胞]高于外周血[(18±3)拷贝/10。细胞(U值均为0.00,P值均〈0.05)];肠黏膜相关淋巴组织HIV-1DNA水平从平均10714拷贝/10^6细胞降低至平均1701拷贝/10^6细胞,差异有统计学意义(Z=-2.934,P〈0.05);外周血HIV-1DNA水平从平均66拷贝/10。细胞降低至平均18拷贝/10^6细胞,差异有统计学意义(Z=-2.934,P〈0.05)。结论肠黏膜相关淋巴组织及淋巴结是HIV-1DNA储存的重要场所。 Objective To study HIV-1 DNA levels in different parts of HIV patients during the early stage of antiretroviral therapy. Methods The peripheral blood, gut associated lymphoid tissues and lymph nodes samples were collected before and 12 weeks after treatment in regular follow-up HIV-1/AIDS patients in Beijing Youan Hospital ( n = 11 ). The average age was 39 years old ( 25 to 55). Mononuelear Cells were isolated by density gradient centrifugation and then used DNA extraction kit to extract DNA. Real- time quantitative polymerase chain reaction was used to examine HIV-1 DNA copy-number. Non-parametric test was used to analyse the differences of HIV-1 DNA copy numbers among groups. Results Before treatment, HIV-1 DNA copy-number in both gut associated lymphoid tissues (10 714 ± 2043 ) copies/10^6 cells and lymph nodes (9145 ± 1202) copies/106 cells were higher than that in the peripheral blood (66 ± 8 ) copies/106 cells ( U = 0. 00 ,P 〈 0. 05 ) , There was no significant difference between lymph nodes and gut associated lymphoid tissues ( U = 46. 00,P 〉 0. 05 ). After 12 weeks of treatment, HIV-1 DNA copy-number in both gut associated lymphoid tissues (1701 ± 790) copies/106 cells and lymph node (11 591 ± 1781 ) copies/106 cells were higher than the peripheral blood ( 18 ± 3) copies/106 cells (Z = - 2. 934 ,P 〈 0. 05). There was a significant reduction of DNA copy-number in gut associated lymphoid tissues and peripheral blood after treatment (Z = - 2. 934,P 〈 0. 05). Conclusion Gut associated lymphoid tissues and lymph nodes may be important latent reservoirs for HIV-1 DNA.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2012年第5期453-456,共4页 Chinese Journal of Laboratory Medicine
基金 国家“十二五”传染病重大专项资助项目(2012ZX10001-003) 北京市科委资助项目(130906003040391) 国家自然科学基金资助项目(81101250)
关键词 获得性免疫缺陷综合征 抗逆转录病毒治疗 高效 淋巴组织 淋巴结 HIV-1 DNA 病毒 Acquired immunodeficiency syndrome Antiretroviral treatment, highly active Lymphoid tissue Lymph nodes HIV-1 DNA,viral
  • 相关文献

参考文献12

  • 1Soudeyns H, Campi G, Rizzardi GP, et at. Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality. Blood, 2000, 95 : 1743- 1751.
  • 2Siliciano JD, Kajdas J, Finzi D, et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD^4+ T cells. Nat Med, 2003, 9:727-728.
  • 3Strain MC, Gtinthard HF, Havlir DV, et al. Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence. Proc Natl Acad Sci U S A, 2003, 100:4819-4824.
  • 4Alexaki A, Liu Y, Wigdahl B. Cellular reservoirs of HIV-1 and their role in viral persistence. Curr HIV Res, 2008, 6:388-400.
  • 5l Brussel A, Sonigo P. Analysis of early human immunodeficiency virus type 1 DNA synthesis by use of a new sensitive assay for quantifying integrated provirus. J Virol, 2003, 77 : 10119-10124.
  • 6Butler SL, Hansen MS, Bushman FD. A quantitative assay for HIV DNA integration in vivo. Nat Med, 2001, 7:631-634.
  • 7Zhu W, Jiao Y, Lei R, et al. Rapid turnover of 2-LTR HIV-1 DNA during early stage of highly active antiretroviral therapy. PLoS One, 2011, 6:e21081.
  • 8焦艳梅,吴昊.HIV-1潜伏库研究进展[J].首都医科大学学报,2009,30(5):639-642. 被引量:8
  • 9Waki K, Freed EO. Macrophages and Cell-Cell Spread of HIV-1. Viruses, 2010, 2:1603-1620.
  • 10] Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol, 2008, 83:804-809.

二级参考文献26

  • 1Ho D D,Neumann A U,Perelson A S,et al.Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection[J].Nature,1995,373:123-126.
  • 2Perelson A S,Essunger P,Can Y,et al.Decay characteristics of HIV-1-infected compartments during combination therapy[J].Nature,1997,387:188-191.
  • 3Natarajan V,Bosche M,Metcalf J A,et al.HIV-1 replication in patients with undetectable plasma virus receiving HAART.Highly active anfiretruviral therapy[J].Lancet,1999,353:119-120.
  • 4Pope M,Haase A T.Transmission,acute HIV-1 infection and the quest for strategies to prevent infection[J].Nat Med,2003,9:847-852.
  • 5Agosto L M,Yu J J,Dai J,et al.HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration[J].Virology,2007,368:60-72.
  • 6Blazkova J,Trejbalova K,Gondois-Rey F,et al.CpG methylation controls reactivation of HIV from latency[J].PLoS Pathog,2009,5:e1000554.
  • 7Jeeninga R E,Westerhout E M,van Gerven M L,et al.HIV-1 latency in actively dividing human T cell lines[J].Retrovirology,2008,5:37.
  • 8Ramratnam B,Mittler J E,Zhang L,et al.The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy[J].Nat Med,2000,6:82-85.
  • 9Lefebvre J C,Durant J,Koechlin A,et al.HIV-1 and persistent clinical latency,TAR element analysis and improved method for in vitro viral reactivation[J].J Clin Virol,2007,38:348-352.
  • 10Fraser C,Fergusen N M,Ghani A C,et al.Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs[J].AIDS,2000,14:659-669.

共引文献7

同被引文献4

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部